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Abstract
Background: Kaixinjieyu (KJ), derived from Kaixin and Sini powder, is an effective Chinese herbal medicine preparation
used in the treatment of vascular depression (VD). We hypothesize that broad antidepressant effect of KJ results from
the improved neurovascular unit (NVU) function via neurogenesis, permeability of blood–brain barrier (BBB) and
balance of the fibrinolytic system.
Methods: A VD model of rat was established by chronic unpredictable mild stress and separation after ligation of the
bilateral common carotid arteries. The rats were treated with KJ and fluoxetine hydrochloride (FLU) for 21 days,
respectively. The behavior and cerebral perfusion were investigated and then NVU functions including neurogenesis,
permeability of BBB and balance of the fibrinolytic system were studied using a number of biomarkers and TUNEL
assay.
Results: KJ significantly increased sucrose preference, moving distance, number of rearing and cortical blood flow. NVU
functions measured by brain-derived neurotrophic factor (BDNF), tropomyosin receptor kinase B (TrkB) and tissue
plasminogen activator (t-PA) proteins and mRNA, zona occludens protein-1 (ZO-1), occludin and claudin-5 proteins
increased significantly, whereas, plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-2) proteins,
mRNA and apoptotic rates of neurons decreased significantly with treatment of KJ. FLU has a function similar to KJ in
behavior, regulation of BDNF, TrkB, MMP-2, occludin and apoptotic rates of cells.
Conclusions: KJ has function of reducing depression-like behavior and improving cerebral hypoperfusion, which might
be mediated by the up-regulation of neurogenesis and tight junction of BBB, and balance of the fibrinolytic system.
The results imply that KJ is better than FLU in improving cerebral hypoperfusion and the fibrinolytic system.
Keywords: Kaixinjieyu, Chinese herbal medicine, Vascular depression, Neurovascular unit, Blood–brain barrier,
Neurogenesis
Background
Vascular depression (VD) is defined as a subtype of late-
life depression associated with vascular diseases or cere-
brovascular risk factors such as age, stroke, myocardial
infarction, hypertension, hyperlipidemia and diabetes [1,
2]. Studies have shown that about 3.4 % adults of 50-
years and older suffer from VD. Among adults who meet
the criteria for lifetime major depression, over one-in-
five are considered to have the VD subtype [3]. VD has
three subtypes, namely, post-stroke depression, MRI-
defined VD and depression with cerebrovascular dis-
order risk factors [4]. Their common pathology is
chronic cerebral ischemia caused by cerebrovascular dis-
eases [5]. The event of stressful life notably results in the
occurrence of VD [6].
A number of associated diseases of VD means compli-
cated therapeutic strategies [1, 7]. For VD patients, de-
pressive syndrome is not the primary disease but can be
considered as one of the clinical manifestations in the
wide symptom spectrum of the cerebral small vessel
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diseases [7]. VD is poorly responsive to antidepressants
and the therapeutic strategy is often significantly differ-
ent from other depressions. Therefore, VD is a useful
concept for clinical interventions [8]. White-matter
hyper intensities in the left hemisphere [9], especially in
the cingulum bundle adjacent to the hippocampus [10],
global vascular risk [11], magnetic resonance imaging
findings and neuropsychological assessment [12] have
been used as predictors of poor response to antidepres-
sants in VD patients.
Earlier studies have shown that monoamine and its re-
ceptors are likely to have antidepressant-like effects only
at the beginning, and subsequently, it is neural plasticity
that generates the long-lasting antidepressant effects
[13]. The current hypothesis of depression points toward
neuroplasticity-related malfunction in information pro-
cessing within neural networks regulating mood [14, 15].
Neural plasticity and neurogenesis have become one of
the main targets of antidepressants. Gudmundsson et al.
reported that elderly women with major depressive dis-
order exhibited higher cerebrospinal fluid /serum albu-
min ratios compared to women without depression
which indicates that blood–brain barrier (BBB) hyper-
permeability occurs in major depressive disorder [16].
Increasingly the BBB, which is formed by endothelial
cells, is no longer viewed as an isolated conception, but
as a major component of an integrated neurovascular
unit (NVU) [17]. The NVU consists of neurons, endo-
thelial cells, pericytes and glia, which are tightly coupled
to control cerebrovascular function. This structural and
functional unit may have major roles in VD pathogenesis
[18]. Restoration of NVU function is considered as one
of the main therapeutic targets.
The previous research has shown that Kaixinjieyu (KJ),
a Chinese herbal medicine preparation from Kaixin and
Sini powder, is capable of enhancing vital Qi (Chinese
words, meaning the function of body and the ability of
health maintenance) and reducing depression; it could
improve both cognitive and physical function of VD pa-
tients clinically [19]. KJ has antidepressant effects on be-
havior and production of monoamines such as the
neurotransmitters serotonin and norepinephrine and
serotonin receptor of chronic unpredictable mild stress
(CUMS) in rats [19]. Moreover, the previous study has
demonstrated that KJ can increase the expression of glial
fibrillary acidic protein and brain-derived neurotrophic
factor (BDNF) in the hippocampus in VD model [20].
However, the effect of KJ on the dysfunction of neuro-
vascular unit in VD is still unclear, especially in the pre-
frontal cortex and hippocampus, which are central in
the pathophysiology of mood disorders [14].
In the present study, the antidepressant effects and a
number of biomarkers of NVU functions including
neurogenesis, fibrinolytic system and permeability of
BBB were investigated in KJ-treated VD rats, such as
BNDF, tropomyosin receptor kinase B (TrkB), tissue
plasminogen activator (t-PA), plasminogen activator
inhibitor-1 (PAI-1), matrix metalloproteinase-2 (MMP-
2), matrix metalloproteinase-9 (MMP-9), zona occludens
protein-1 (ZO-1), occludin and claudin-5 [21–23].
Methods
Preparation and compositional analysis of KJ
KJ is a prescription originated from eight herbal plants in-
cluding Bupleurum chinense DC. (Chai-Hu), Paeonia lacti-
flora Pall. (Chi-Shao), Morinda officinalis How (Ba-Ji-
Tian), Poria cocos (Schw.) Wolf (Fu-Ling), Panax ginseng
C. A. Mey. (Ren-Shen), Citrus aurantium L.(Zhi-Shi), Po-
lygala tenuifolia Willd. (Yuan-Zhi) and Glycyrrhiza uralen-
sis Fisch. (Gan-Cao), in weight ratio of 3:3:3:3:2:2:2:2.
These plant materials were bought from Beijing Bencao
Fangyuan Pharmaceutical Co., Ltd (Beijing, China). Panax
ginseng C. A. Mey. and Poria cocos (Schw.) Wolf were
grinded into powder of less than 100 meshes in size. Other
herbs were decocted twice, each for 1.5 h. The filtrates
were merged and concentrated to obtain a cream (relative
density of 1.30–1.35 g/cm3 at 55–60 °C) by evaporation
under reduced pressure. The preparation (KJ) was made
up with the powder and cream by weight ratio of 1.2:1, and
analyzed for composition by high performance liquid chro-
matography (HPLC).
The test solution was prepared by dissolving KJ in
methanol, and analyzed on an Agilent 1200 HPLC (DAD)
system with an C18 analytical column (250 × 4.6 mm,
5 μm). The mobile phase was consisted of acetonitrile and
water in gradient elution. For quality control, standards
including ginsenosides Rg1, Re and Rb1 for Panax ginseng
C. A. Mey., nistose for Morinda officinalis How,
Table 1 Primer pairs used for real-time PCR
Gene Primer Product length (bp)
MMP–2 F 5′-ACACCCTCAAGAAGATGCAGA-3′ 237
R 5′-ATACTTTTAAGGCCCGAGCAA-3′
MMP–9 F 5′-TTTGGAAACGCAAATGGTG-3′ 210
R 5′-TGGAAATACGCAGGGTTTG-3′
t–PA F 5′-AGACATCACCTCACACCCTTG-3′ 194
R 5′-TTCCAGGGACCACTCTGTATG-3′
PAI–1 F 5′-GCCCCACTTCTTCAAGCTC-3′ 160
R 5′-CAGGCGTGTCAGCTCATTT-3′
BDNF F 5′-GCATCAGAAAAAGAGGCAAAC-3′ 194
R 5′-AGGCTACGTGAAGTCTTCCAA-3′
TrkB F 5′-GTCTGCTGAAGCCTGCATATC-3′ 191
R 5′-ATGAGTGCGTTGGAATGAAAC-3′
GAPDH F 5′-CCATGGAGAAGGCTGGG3′ 195
R 5′-CAAAGTTGTCATGGATGACC-3′
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paeoniflorin for Paeonia lactiflora Pall., saikosaponin
A and D for Bupleurum chinense DC., Glycyrrhizic
acid ammonium salt and liquiritin for Glycyrrhiza
uralensis Fisch., naringin, neohesperidin and hesperi-
din for Citrus aurantium L. were used. All the stan-
dards were purchased from National Institutes for
Food and Drug Control (Beijing, China).
Animal, model and treatment
Eighty male Sprague–Dawley rats (250 ± 10 g, 7 weeks
old), SPF grade, were purchased from Vital River Lab
Animal Technology Co., Ltd (Beijing, China). All experi-
ments were approved by the Ethical Committee of
Guang’anmen Hospital, China Academy of Chinese
Medical Sciences (Beijing, China). The animals were
cared in accordance with the “Guide for the Care and
Use of Laboratory Animals” of the National Institutes of
Health. Rats were initially divided into two groups:
sham-operated rats (sham group, n = 8) were fed in a
breeding box each with 4 rats normally and a permanent
ligation of bilateral common carotid arteries (LBCCA)
group (n = 72). The rats were anesthetized with intraper-
itoneal chloral hydrate (350 mg/kg). Through a midline
cervical incision, the bilateral common carotid arteries
were exposed and double ligated with silk sutures. The
sham-operated rats were treated in a manner similar to
that of the operated ones, except that the common ca-
rotid arteries were not occluded [24]. Forty-two survived
rats were randomly divided into 5 groups for sucrose
preference test (SPT) and fed individually in a box and
received CUMS for 21 consecutive days from 7 days
post LBCCA. Some were treated with KJ at dose of
1.8 g/kg/day (KJ-H, n = 9), 0.9 g/kg/day (KJ-M, n = 9),
0.45 g/kg/day (KJ-L, n = 8) and fluoxetine hydrochloride
at dose of 2.0 mg/kg/day (FLU, n = 8). KJ and FLU were
administered for 21 consecutive days from 7 days
post LBCCA. The others were treated with nothing
as VD model (VD, n = 8) [20]. Mild stressors used
included placing an empty bottle in cages for 1 h,
nipping the tail for 1 min, swimming in 4 °C water
for 5 min, heating in 45 °C oven for 5 min, inversion
of the light/dark cycle for 24 h, cage tilting for 24 h,
fasting for 24 h, water deprivation for 24 h, wet bed-





















































Fig. 1 Results of the behavior tests in VD model following KJ treatment.
a Sucrose preference test. #P< 0.05 vs. VD group, *P< 0.05 vs. sham
group. b Distance and number of rearing in open-field test. #P< 0.05,
##P< 0.01 vs. VD group, %P< 0.01 vs. sham group in distance; *P< 0.05
vs. VD group, &P< 0.05 vs. sham group in rearing
Table 2 The main bioactive compounds and composition analysis of KJ
Origin of Herb Compound Formula Content (mg/g)
Morinda officinalis How Nistose C24H42O21 2.50
Paeonia lactiflora Pall. Paeoniflorin C23H28O11 3.06
Bupleurum chinense DC. Saikosaponin A C42H68O13 0.28
Saikosaponin D C42H68O13 0.13
Glycyrrhiza uralensis Fisch. Glycyrrhizic acid Ammonium salt C42H65NO16 0.95
Liquiritin C21H22O9 0.52
Citrus aurantium L. Naringin C27H32O14 3.72
Neohesperidin C28H34O15 1.06
Hesperidin C28H34O15 15.24
Panax ginseng C. A. Mey. Ginsenoside Rg1 C42H72O14 1.19
Ginsenoside Re C48H82O18 1.01
Ginsenoside Rb1 C54H92O23 1.44
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electric shock (60 V, 1 mA, lasting 10 s at an interval
of 1 min, 5 times). Rats received one of these
stressors per day, but the same stressor was not ap-
plied in two consecutive days.
Behavior tests
SPT and open-field test (OFT) were carried out after
CUMS as described [25]. The consumptions of 1 %
sucrose solution and distilled water in 2 h were mea-
sured. The sucrose preference was calculated as the
percentage of the sucrose solution consumed to the
solution (sucrose solution and water) consumed.
OFT was tested using the OFT-100 video analysis
system. A rat was placed in the center of the box in-
dividually and recorded for its moving distance and
the number of rearing.
Cerebral perfusion
All rats were anesthetized with 10 % chloral hydrate
(350 mg/kg) after the behavioral tests. Skin was removed
and skull fully exposed. The cerebral perfusion was cap-
tured with a Perfusion Speckle Imager (Perimed AB,
Sweden). Data were processed using PIMSoft and the
means of cortical blood flow (CBF) in the left and right
hemispheres were calculated.
The terminal transferase dUTP nick end labeling (TUNEL)
assay
Rats were perfused alive with 4 °C normal saline and de-
collated. Right cerebral tissues were fixed in paraformal-
dehyde (40 g/L) overnight, embedded and sectioned.
Sections were processed for the TUNEL assay using In-
Situ Cell-Death Detection (POD) kit, (Roche, Penzberg,
Germany) according to the manufacturer’s instructions
Fig. 2 Cortical blood flow in VD model following KJ treatment. a the microcirculation imaging of cerebrum. The white line-encircled area is the
region of interest. VD rats display a decreased trend of the cortical blood flow (CBF) compared with the sham group. Rats in KJ-H, KJ-M and FLU
groups display a notable increase of the CBF. b CBF of left and right hemisphere. Pu is a unit of cortical blood flow. #P < 0.05, ##P < 0.01 vs. VD
group; %P < 0.01 vs. sham group in the left hemisphere; *P < 0.05, **P < 0.01 vs. VD group; &&P < 0.01 vs. sham group in the right hemisphere
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to reveal the degree of apoptosis in cerebral tissues. The
investigators were blinded to the animal grouping. For
each rat, four photographs were randomly selected. The
apoptotic rate was obtained by counting the TUNEL
positive cells compared to all the visible cells. A mean
value was calculated from four values and the final
values were subjected to statistical analysis.
Immunohistochemical analysis
Immunohistochemistry (IHC) was carried out with anti-
bodies against BDNF (1:80, Abcam, Cambridge, MA,
USA), TrkB (1:100, Abcam, Cambridge, MA, USA), t-PA
(H-90) (1:200, Santa Cruz, CA, USA), PAI-1 (H-135)
(1:200, Santa Cruz, CA, USA), MMP-2 (8B4) (1:200,
Santa Cruz, CA, USA) and MMP-9 (C-20) (1:200, Santa
Cruz, CA, USA). The proteins were quantified by inte-
gral optical density (IOD) with Image Pro Plus 6.0. For
each rat, four sections were used to calculate the means.
Real-time PCR analysis
Determination of BDNF and TrkB mRNA was carried
out in the hippocampus, t-PA, PAI-1, MMP-2 and
MMP-9 mRNA were analyzed in the prefrontal cortex
tissue by real-time PCR. Total RNA was extracted using
Trizol reagent (Invitrogen, USA) according to the manu-
facturer’s instructions. Then reverse transcription and
real-time PCR reactions were performed with Revert
Aid™ first strand cDNA synthesis kit (MBI, USA) and
SYBR® Green PCR Master Mix (ABI, USA), respectively.
The primers were designed with primer 3 web based on
published rat cDNA sequences (Table 1). All primers
were purchased from SBS Genetech Co., Ltd. (Beijing,
China). Quantification of mRNA levels relative to
GAPDH (a housekeeping gene) was made with the 2-
△△CT method.
Western blot analysis
Prefrontal cortex tissues were washed and then lysed on
cold RIPA buffer (50 mM Tris–HCl pH 7.4, 150 mM
NaCl, 1 % TritonX-100, 1 % sodium deoxycholate, and
0.1 % SDS) containing a protease inhibitor cocktail
(Roche, Penzberg, Germany). The protein concentration
of each homogenate was determined using a BCA kit.
Twenty-four μg of soluble protein was subjected to
Fig. 3 TUNEL assay for analysis of apoptotic cells in brain tissues. a TUNEL assay of brain tissues. Cells with shrunken brown stained nuclei were
considered positive. The TUNEL-positive cells were mainly observed in cortex. Scale bar: 50 μm. b Quantitative analysis of TUNEL-positive cells.
##P < 0.01 vs. VD group; ***P < 0.001 vs. sham group
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SDS-PAGE and electro-transferred onto PVDF mem-
branes, which were then immunostained with the fol-
lowing primary antibodies against ZO-1 (1:1000, Thermo
Fisher, Rockford, IL, USA), occludin (1:2000, Abcam,
Cambridge, MA, USA), claudin-5 (1:1000, Thermo Fisher,
Rockford, IL, USA), and β-actin (1:1000, Sigma, St Louis,
MO). The membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies. Immunore-
active proteins were detected by an enhanced chemilu-
minescence system.
Data analysis
The SPSS 16.0 (SPSS Inc., USA) software was used for
the analysis. Data were expressed as mean ± standard
error. The data were statistically evaluated by one-way
analysis of variance, and a post hoc analysis was per-
formed by the Fisher’s least significant difference test. P
< 0.05 was regarded as statistically significant.
Results
Composition of KJ preparation
As shown in Table 2, twelve compounds from the herbs
were identified and the content of each compound was
in the range of 0.13 to 15.24 mg/g. The contents of hes-
peridin, naringin, paeoniflorin and nistose were relatively
higher among the identified compounds.
Behavior test
SPT and OFT were carried out to investigate the
depression-like behavior. VD rats displayed a decreased
sucrose preference compared with the sham group
(P < 0.05); rats in KJ-H, KJ-M and FLU groups had
significant increases in sucrose preference compared
with the VD group (P < 0.05, Fig. 1a). In OFT, VD
rats showed a decreased moving distance (P < 0.01)
and the number of rearing (P < 0.05) compared with
the sham group; rats in KJ-H and FLU groups had
significant increases in the moving distance (P < 0.01,
P <0.05) and number of rearing (P < 0.05) compared
with the VD group (Fig. 1b).
Cerebral perfusion
The CBF was reduced in VD rats compared with the
sham rats (P < 0.01); rats in KJ-H and KJ-M groups dis-
played significant increase in the CBF compared with
the VD group (P < 0.01, P < 0.05, respectively, Fig. 2).
Fig. 4 IHC of BDNF protein in the hippocampus. BDNF is mainly expressed in the cytoplasm of neurons and glial cells as yellow or yellow-brown
colored staining. More positive-staining cells are in the sham, FLU and KJ-H groups relatively. Scale bar: 50 μm
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TUNEL assay
The TUNEL-positive cells were mainly observed in cortex
but fewer in hippocampus. More cells were apoptotic in
VD rats compared with the sham rats (P < 0.001); rats in
KJ-H and FLU groups displayed significant decrease in
apoptotic rates compared with the VD group (P < 0.01,
Fig. 3).
Protein and mRNA of BDNF and TrkB
IHC-staining showed that BDNF and TrkB were
mainly expressed in cytoplasm of neurons and glial
cells as yellow or yellow-brown colored staining.
BDNF and TrkB in the positive-cells were mainly lo-
cated in the cytoplasm. The IOD of BDNF and TrkB
positive-cells decreased significantly in the VD group
compared with the sham group (P < 0.05). Compared
with VD group, IOD of BDNF and TrkB positive-
cells increased significantly in FLU and KJ-H groups
(P < 0.05, Figs. 4, 5, 6a and c).
The levels of BDNF and TrkB mRNA decreased signifi-
cantly in the VD group (P < 0.05, P < 0.01, Fig. 6b, d) com-
pared with the sham group. Whereas, compared with VD
group, the levels of BDNF mRNA increased significantly in
KJ-H, KJ-M and FLU groups (P < 0.05 or P < 0.01, Fig. 6b),
TrkB mRNA increased significantly in KJ-H, KJ-M and KJ-
L groups (P < 0.05 or P < 0.01, Fig. 6d).
Protein and mRNA levels of t-PA, PAI-1, MMP-2 and
MMP-9
In IHC-stained slices, t-PA, PAI-1, MMP-2 and
MMP-9 were expressed mainly in cytoplasm and a
little in nucleus of neurons and glial cells as yellow
or yellow-brown staining. T-PA and PAI-1 were also
slightly expressed in the cytoplasm of endothelial
cells. The IOD of t-PA positive-cells decreased sig-
nificantly, PAI-1 and MMP-2 positive-cells increased
significantly in the VD group compared with the sham
group (P < 0.05 or P < 0.01, Figs. 7, 8, 9, 10a, c and e). IOD
of t-PA positive-cells increased significantly in KJ-H and
FLU groups compared with the VD group (P < 0.05, Figs. 7
and 10a); IOD of PAI-1 positive-cells decreased signifi-
cantly in KJ-H group (P < 0.05, Figs. 8 and 10c); IOD of
MMP-2 positive cells decreased significantly in KJ-H, KJ-
M and FLU groups (P < 0.05, Figs. 9 and 10e). There was
no significant difference in IOD of MMP-9 positive-cells
among all groups.
Fig. 5 IHC of TrkB protein in the hippocampus. TrkB is mainly expressed in the cytoplasm of neurons and glial cells as yellow or yellow-brown
colored staining. More positive-staining cells are in the sham, FLU and KJ-H groups relatively. Scale bar: 50 μm












































































































Fig. 6 The levels of BDNF and TrkB proteins and mRNA in the hippocampus. a IOD of BDNF by IHC. b BDNF mRNA levels by real-time PCR. c IOD
of TrkB by IHC. d TrkB mRNA levels by real-time PCR. #P < 0.05, ##P < 0.01 vs. VD group; **P < 0.01 vs. sham group
Fig. 7 IHC of t-PA protein in the cerebrum. T-PA is expressed mainly in the cytoplasm and a little in the nucleus of neurons and glial cells as yellow or
yellow-brown colored staining. More positive-staining cells are in the sham, FLU and KJ-H groups relatively. Scale bar: 50 μm
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Compared with the sham group, t-PA mRNA decreased
significantly (P < 0.05), PAI-1 and MMP-2 mRNA in-
creased significantly (P < 0.05, P < 0.01) in the VD group
(Fig. 10b, d and f). Levels of t-PA mRNA increased and
PAI-1 mRNA decreased significantly in KJ-H group com-
pared with the VD group (P < 0.05) (Fig. 10b, d). MMP-2
mRNA levels decreased significantly in KJ-H, KJ-M and
FLU groups (P < 0.05 or P < 0.01) (Fig. 10f). There was no
significant difference in MMP-9 mRNA levels among all
groups.
Levels of ZO-1, occludin and claudin-5
As shown in Fig. 11a, the expression of tight junction
biomarkers including ZO-1, occludin and claudin-5 was
significantly decreased in the VD group compared with
sham group (P < 0.01 or P < 0.001). The expression of
ZO-1 increased significantly in KJ-H group compared
with VD group (P < 0.05, Fig. 11b). The expression of
occludin increased significantly in KJ-H, KJ-M and FLU
groups compared with VD group (P < 0.001, P < 0.05, P
< 0.01, Fig. 11c). The expression of claudin-5 increased
significantly in KJ-H group compared with VD group
(P < 0.05, Fig. 11d).
Discussion
Effects of KJ on depression-like behavior and cerebral
perfusion
A number of rat VD models have been established, such
as those resulted from aging [26], high-fat feeding and
CUMS [27], individual feeding in a box post LBCCA
and treated with CUMS [20]. The VD model established
by feeding the rats individually after LBCCA and in
combination with CUMS is considered to be ideal in
simulating the common pathology (chronic cerebral hy-
poperfusion caused by cerebrovascular disease) [20]. In
the present study, the VD models were evaluated by
SPT, OFT and cerebral blood flow. The rats showed in-
creased behavioral obstacles and significantly reduced
cerebral perfusion after modelling, indicating that the
model was successful in mimicking the core VD symp-
toms, such as anhedonia, declined athletic activity and
reduced curiosity and cerebral perfusion. However, the
findings of the present study i.e. the CBF in the VD rats
decreased significantly 28 days post LBCCA are different
from earlier studies [28, 29], which reported that the
perfusion drops sharply immediately after occlusion [28],
persists for several days after permanent LBCCA [29].
Fig. 8 IHC of PAI-1 protein in the cerebrum. PAI-1 is expressed mainly in the cytoplasm and a little in the nucleus of neurons and glial cells as
yellow or yellow-brown colored staining. Less positive-staining cells are in the sham and KJ-H groups relatively. Scale bar: 50 μm
Pan et al. BMC Complementary and Alternative Medicine  (2015) 15:291 Page 9 of 14
The compensatory redistribution via the vertebrobasilar
network progressively restores the blood flow in almost
all brain regions, and the cerebral blood perfusion is in-
distinguishable from controls after 1 month [28, 29].
The inconsistency suggests that CUMS might increase
the duration of cerebral hypoperfusion, and further
study is needed to clarify this.
The data demonstrate that that KJ at high and medium
doses and FLU have similar antidepressant effects in
terms of sucrose preference, moving distance and num-
ber of rearing. Furthermore, KJ, particularly at high dose,
could improve the cerebral hypoperfusion better than
FLU, suggesting it might be a better antidepressant op-
tion. The analysis shows that hesperidin (C28H34O15) from
Citrus aurantium L. is the bioactive compound of the
highest-content in KJ preparation. It has been shown to be
able to penetrate the BBB [30] and prevent the neurodegen-
eration caused by conditions such as ischemia/reperfusion
and promote healthy brain functions [31]. Therefore, Citrus
aurantium L. might play a key role in improving the cere-
bral hypoperfusion and alleviating the depression. Since a
number of compounds have been identified in the
preparation, more works are needed to elucidate their roles
in antidepressant effects.
Mechanism of KJ on restoration of NVU function
Chronic cerebral hypoperfusion induced by LBCCA is
shown to result in hypoxia and ischemia in the brain, lead-
ing to impaired BBB [32]. A number of studies have
shown that impaired BBB is often associated with depres-
sion [33, 34]. Recent studies have shown that oxidative
stress and neuro inflammation in depression patients
could cause BBB hyperpermeability and NVU dysfunction
[17]. To better understand the mechanism of KJ effect on
NVU, a number of biomarkers related to neurogenesis, fi-
brinolytic system and permeability of BBB were investi-
gated at transcriptional and (or) translation levels.
Neurotrophins play important roles in neuron survival,
plasticity, neurogenesis and synaptogenesis. BDNF as
one of neurotrophins is shown to regulate the neurogen-
esis in adult hippocampus and generation of 5-hydroxy
tryptophan, γ-aminobutyric acid and dopamine in cen-
tral nervous system, and is involved in the plasticity of
neurons [35]. Binding of BDNF to its high-affinity
Fig. 9 IHC of MMP-2 protein in the cerebrum. MMP-2 is expressed mainly in the cytoplasm and a little in the nucleus of neurons and glial cells as
yellow or yellow-brown colored staining. More positive-staining cells are in the VD and KJ-L groups relatively. Scale bar: 50 μm
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receptor TrkB is found to activate MAPK, PI3-K and
CaMK signal pathways, and cAMP response element
binding protein and improve the survival and plasticity
of neurons [36, 37]. The results show that KJ treatment
up-regulates the expression of BDNF and TrkB at trans-
lational and transcriptional level and down- regulates
the apoptotic rates of neurons in the VD model, suggest-
ing that the antidepressant-like effects of KJ might be at-
tributed to the neurogenesis in the cerebrum.
The t-PA/plasminogen proteolytic cascade is known to
be important for thrombolysis [38]. PAI-1 is the major
inhibitor for t-PA [39]. Study shows that women with
major depressive disorder have higher PAI-1 levels than
normal controls [40], and PAI-1 gene variants may play
a role in major depressive disorder susceptibility and in
the acute therapeutic response to selective serotonin re-
uptake inhibitors [41]. In addition, PAI-1 could reduce
the conversion of plasminogen into plasmin, reduce the
cleavage of pro-BDNF to mature BDNF and weaken the
protection of nerve by BDNF [42]. This study shows that
t-PA in VD rat declines, while PAI-1 increases, resulting
in unbalanced fibrinolytic system. KJ could partially re-
store the fibrinolytic system, which might contribute to
improved cerebral perfusion.
The BBB is a tightly sealed barrier between the circu-
lating blood and the central nervous system, consisting
of brain microvascular endothelial cells which are char-
acterized by the presence of tight junctions (TJs) and
lack of fenestrae, then confer the low paracellular per-
meability of BBB [43, 44]. The main structural barrier
proteins are occludin, zona occludens (ZO)-1 and
claudin-5, and these are considered to be sensitive indi-
cators of normal versus disturbed functional states of
the BBB [45]. Yet, MMPs have the function of disrupting
endothelial junction proteins in BBB in vitro and in-
crease BBB opening [46, 47]. Nakaji [48] reported that
MMP-2 was associated with BBB permeability and in-
creases the migration of neutrophil and inflammation
factors, resulting in damage in the limbic system. Earlier


































































































































































Fig. 10 The levels of T-PA, PAI-1and MMP-2 proteins and mRNA in the prefrontal cortex. a, c, e IOD of t-PA, PAI-1and MMP-2 by IHC. b, d, f T-PA,
PAI-1and MMP-2 mRNA levels by real-time PCR. #P < 0.05, ##P < 0.01 vs. VD group; *P < 0.05, **P < 0.01 vs. sham group
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ischemia/reperfusion and activation of it occurred at 12,
24 and 48 h after reperfusion [49]. The results show that
there is no obvious difference in MMP-9 in the VD rats,
which might be because the MMP-9 is mainly involved
in the acute phase but not in the chronic phase of cere-
bral hypoperfusion. The up-regulated levels of MMP-2
protein and mRNA, down-regulated levels of ZO-1,
occludin and claudin-5 in the VD rats are partially
returned to the normal levels as in the sham group with
treatment of KJ. The normalization might reduce the
BBB hyperpermeability and inflammation in the VD rats.
It might also be responsible for the antidepressant ef-
fects of KJ.
Conclusions
The present study indicated that KJ could reduce
depression-like behavior and improve chronic cerebral
hypoperfusion in VD rats. The effects might be mediated
by the up-regulation of neurogenesis and tight junction
of BBB, and balance of the fibrinolytic system, which re-
sult in restoration of NVU function. The results imply
that KJ is better than FLU in improving cerebral hypo-
perfusion and the fibrinolytic system.
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